Hindustan Foods Ltd
Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories
- Market Cap ₹ 6,513 Cr.
- Current Price ₹ 554
- High / Low ₹ 686 / 422
- Stock P/E 63.0
- Book Value ₹ 72.5
- Dividend Yield 0.00 %
- ROCE 14.9 %
- ROE 14.0 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 35.4% CAGR over last 5 years
- Company's median sales growth is 43.6% of last 10 years
Cons
- Stock is trading at 7.64 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Diversified - Large
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 6m | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 17 | 24 | 38 | 139 | 492 | 772 | 1,407 | 2,021 | 2,383 | 2,381 | 2,734 | |
4 | 23 | 22 | 35 | 128 | 459 | 716 | 1,317 | 1,905 | 2,236 | 2,219 | 2,521 | |
Operating Profit | -0 | -6 | 2 | 3 | 10 | 33 | 56 | 90 | 115 | 147 | 163 | 212 |
OPM % | -15% | -33% | 9% | 8% | 7% | 7% | 7% | 6% | 6% | 6% | 7% | 8% |
0 | 11 | 0 | 0 | 1 | 1 | 1 | 3 | 5 | 5 | 10 | 19 | |
Interest | 1 | 2 | 1 | 1 | 1 | 8 | 11 | 19 | 20 | 27 | 38 | 47 |
Depreciation | 0 | 1 | 1 | 1 | 1 | 7 | 11 | 19 | 24 | 29 | 39 | 45 |
Profit before tax | -1 | 2 | -0 | 1 | 9 | 18 | 35 | 54 | 77 | 96 | 96 | 139 |
Tax % | 0% | 0% | -2,980% | 19% | 27% | 35% | 34% | 28% | 35% | 33% | 19% | 26% |
-1 | 2 | 1 | 1 | 6 | 12 | 23 | 39 | 50 | 65 | 78 | 103 | |
EPS in Rs | -0.53 | 1.00 | 0.58 | 0.10 | 0.97 | 1.76 | 2.14 | 3.71 | 4.44 | 5.72 | 6.83 | 8.79 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 66% |
5 Years: | 29% |
3 Years: | 11% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 45% |
5 Years: | 35% |
3 Years: | 27% |
TTM: | 32% |
Stock Price CAGR | |
---|---|
10 Years: | 53% |
5 Years: | 41% |
3 Years: | 15% |
1 Year: | 12% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 16% |
Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 13 | 13 | 13 | 21 | 21 | 23 | 23 | 23 | 24 |
Reserves | -9 | -7 | -5 | 19 | 24 | 51 | 166 | 235 | 285 | 349 | 605 | 829 |
18 | 11 | 13 | 5 | 34 | 100 | 165 | 219 | 274 | 347 | 508 | 510 | |
6 | 8 | 7 | 13 | 46 | 102 | 188 | 265 | 305 | 358 | 402 | 496 | |
Total Liabilities | 20 | 17 | 19 | 50 | 118 | 266 | 540 | 741 | 886 | 1,076 | 1,537 | 1,858 |
8 | 9 | 9 | 9 | 39 | 133 | 250 | 308 | 396 | 402 | 593 | 546 | |
CWIP | 3 | 2 | 2 | 3 | 3 | 0 | 26 | 53 | 9 | 45 | 5 | 99 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 7 | 80 | 84 | 127 |
9 | 6 | 8 | 38 | 75 | 133 | 261 | 377 | 474 | 549 | 855 | 1,086 | |
Total Assets | 20 | 17 | 19 | 50 | 118 | 266 | 540 | 741 | 886 | 1,076 | 1,537 | 1,858 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3 | 1 | 1 | -5 | -5 | -5 | 17 | 73 | 54 | 102 | 48 | 82 | |
-3 | -1 | -1 | -14 | -19 | -40 | -145 | -91 | -103 | -167 | -347 | -118 | |
-0 | 0 | 0 | 24 | 26 | 43 | 153 | 34 | 32 | 47 | 294 | 75 | |
Net Cash Flow | -0 | 0 | 0 | 5 | 2 | -2 | 24 | 16 | -17 | -18 | -6 | 39 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 390 | 47 | 56 | 66 | 76 | 32 | 18 | 13 | 13 | 13 | 15 | 18 |
Inventory Days | 295 | 108 | 37 | 90 | 139 | 54 | 74 | 58 | 52 | 61 | 87 | 88 |
Days Payable | 387 | 184 | 103 | 166 | 237 | 85 | 94 | 74 | 60 | 58 | 67 | 62 |
Cash Conversion Cycle | 298 | -29 | -10 | -10 | -21 | 1 | -2 | -3 | 5 | 16 | 35 | 45 |
Working Capital Days | 107 | -9 | 13 | 36 | 51 | 6 | 11 | 16 | 25 | 27 | 55 | 70 |
ROCE % | -6% | 34% | 8% | 7% | 19% | 22% | 18% | 18% | 18% | 19% | 14% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Refer to the attached PDF file.
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 2d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
21 May - Uploaded audio recording of Q4 and FY2025 analyst/investor call on company website.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
19 May - Refer to the attached PDF file.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
19 May - Hindustan Foods posts Rs 110 Cr PAT in FY25; expands plants, footwear profitable, acquires stake in recycling firm.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
May 2025TranscriptNotesPPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Mar 2018TranscriptNotesPPT
Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.